4
Changes in Ownership
Arcus Biosciences, Inc. Filed Acc 0001724521-23-000067
Chief Financial Officer returned 5,557 shares (to the company)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Goeltz II Robert C. · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-12-18 | Returned to the company : show line 1 in the form 10b5-1 | −2,749 | $17.74 | $48,767 | 56,643 | D |
| 2023-12-19 | Returned to the company : show line 2 in the form 10b5-1 | −2,808 | $18.09 | $50,797 | 53,835 | D |
Loading xslF345X05/wk-form4_1703106591.xml…